Molecular design/
synthesis based on
accumulated
experience/
know-how
Know-how acquired
by pioneering
initiatives
To be developed in
the mental resilience
area
Pursuit of optimal
modalities
A solid business operation system with an excellent management team that can always communicate closely with the Company
Know-hows in development and sales in the psychiatry and neurology area
Strong sales structure through partnering
Sales foundation built by MRs with high expertise in diabetes, psychiatry and neurology area, etc.
Track record of launching competitive in-house products in the areas of infectious diseases and psychiatry and neurology as the third pillar
In addition to the above, Japan and the U.S. have healthcare technology platforms (DrugOME and Digital Innovation) that support the improvement of the probability of success in the research and development and the business return on investment.
Sumitomo Pharma promotes collaboration with partners in Europe and other regions.
You are about to leave the official website of Sumitomo Pharma (Suzhou) Co., Ltd. and be redirected to a third-party website. Please be aware of the risks involved.